Science Translational Medicine Podcast: 26 August 2015

See allHide authors and affiliations

Science Translational Medicine  26 Aug 2015:
Vol. 7, Issue 302, pp. 302pc3
DOI: 10.1126/scitranslmed.aad1902

You are currently viewing the abstract.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution


In this podcast, Scott Dylla discusses a new antibody-drug conjugate that may be effective in treating high-grade pulmonary neuroendocrine cancers.

Listen to Podcast

View Full Text

Stay Connected to Science Translational Medicine